Connors Investor Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
80,288
+281
| +0.4% | +$60.5K | 1.75% | 17 |
|
|
2026
Q1 | $17.4M | Buy |
80,007
+666
| +0.8% | +$148K | 1.61% | 19 |
|
|
2025
Q4 | $18.1M | Buy |
79,341
+155
| +0.2% | +$35.3K | 1.56% | 21 |
|
|
2025
Q3 | $18.3M | Sell |
79,186
-87
| -0.1% | -$17.7K | 1.56% | 18 |
|
|
2025
Q2 | $14.7M | Sell |
79,273
-778
| -1% | -$145K | 1.3% | 35 |
|
|
2025
Q1 | $16.8M | Sell |
80,051
-13,027
| -14% | -$2.53M | 1.66% | 20 |
|
|
2024
Q4 | $16.5M | Sell |
93,078
-2,469
| -3% | -$454K | 1.55% | 23 |
|
|
2024
Q3 | $18.8M | Sell |
95,547
-2,035
| -2% | -$380K | 1.82% | 11 |
|
|
2024
Q2 | $16.7M | Buy |
97,582
+1,920
| +2% | +$318K | 1.74% | 16 |
|
|
2024
Q1 | $17.4M | Sell |
95,662
-3,114
| -3% | -$537K | 1.84% | 13 |
|
|
2023
Q4 | $15.3M | Sell |
98,776
-515
| -0.5% | -$75.1K | 1.72% | 15 |
|
|
2023
Q3 | $14.8M | Sell |
99,291
-2,471
| -2% | -$363K | 1.82% | 12 |
|
|
2023
Q2 | $13.7M | Sell |
101,762
-2,247
| -2% | -$330K | 1.55% | 23 |
|
|
2023
Q1 | $16.6M | Sell |
104,009
-899
| -0.9% | -$137K | 1.95% | 10 |
|
|
2022
Q4 | $17M | Sell |
104,908
-3,706
| -3% | -$568K | 2.12% | 8 |
|
|
2022
Q3 | $14.6M | Buy |
108,614
+2,265
| +2% | +$325K | 1.91% | 10 |
|
|
2022
Q2 | $16.3M | Sell |
106,349
-14,231
| -12% | -$2.17M | 2.05% | 10 |
|
|
2022
Q1 | $19.5M | Sell |
120,580
-10,515
| -8% | -$1.53M | 2.03% | 8 |
|
|
2021
Q4 | $17.7M | Buy |
131,095
+7,724
| +6% | +$912K | 1.74% | 9 |
|
|
2021
Q3 | $13.3M | Buy |
123,371
+13,898
| +13% | +$1.59M | 1.41% | 24 |
|
|
2021
Q2 | $12.3M | Sell |
109,473
-1,260
| -1% | -$142K | 1.28% | 27 |
|
|
2021
Q1 | $12M | Sell |
110,733
-828
| -0.7% | -$88.6K | 1.36% | 28 |
|
|
2020
Q4 | $12M | Sell |
111,561
-6,144
| -5% | -$590K | 1.48% | 22 |
|
|
2020
Q3 | $10.3M | Sell |
117,705
-1,889
| -2% | -$178K | 1.44% | 26 |
|
|
2020
Q2 | $11.7M | Sell |
119,594
-8,681
| -7% | -$764K | 1.74% | 16 |
|
|
2020
Q1 | $9.77M | Buy |
128,275
+110,385
| +617% | +$9.4M | 1.7% | 25 |
|
|
2019
Q4 | $1.58M | Hold |
17,890
| – | – | 0.2% | 92 |
|
|
2019
Q3 | $1.35M | Sell |
17,890
-4,650
| -21% | -$319K | 0.19% | 90 |
|
|
2019
Q2 | $1.64M | Sell |
22,540
-250
| -1% | -$19.6K | 0.22% | 88 |
|
|
2019
Q1 | $1.84M | Sell |
22,790
-119,780
| -84% | -$9.8M | 0.25% | 83 |
|
|
2018
Q4 | $13.1M | Buy |
142,570
+47,045
| +49% | +$4.14M | 2.05% | 10 |
|
|
2018
Q3 | $9.04M | Buy |
95,525
+7,240
| +8% | +$687K | 1.22% | 37 |
|
|
2018
Q2 | $8.18M | Buy |
88,285
+8,723
| +11% | +$852K | 1.15% | 35 |
|
|
2018
Q1 | $7.53M | Buy |
79,562
+1,456
| +2% | +$160K | 1.11% | 38 |
|
|
2017
Q4 | $7.55M | Buy |
78,106
+770
| +1% | +$72.6K | 1.09% | 34 |
|
|
2017
Q3 | $6.87M | Sell |
77,336
-63,935
| -45% | -$4.87M | 1.04% | 40 |
|
|
2017
Q2 | $10.2M | Sell |
141,271
-1,020
| -0.7% | -$68.6K | 1.61% | 16 |
|
|
2017
Q1 | $9.25M | Buy |
142,291
+2,420
| +2% | +$152K | 1.53% | 17 |
|
|
2016
Q4 | $8.76M | Buy |
139,871
+1,016
| +0.7% | +$62K | 1.5% | 19 |
|
|
2016
Q3 | $8.76M | Buy |
138,855
+4,830
| +4% | +$313K | 1.53% | 20 |
|
|
2016
Q2 | $8.3M | Sell |
134,025
-43
| -0% | -$2.62K | 1.61% | 17 |
|
|
2016
Q1 | $7.59M | Buy |
134,068
+4,832
| +4% | +$269K | 1.51% | 19 |
|
|
2015
Q4 | $7.66M | Buy |
129,236
+9,285
| +8% | +$535K | 1.56% | 17 |
|
|
2015
Q3 | $6.53M | Buy |
119,951
+1,475
| +1% | +$96K | 1.47% | 18 |
|
|
2015
Q2 | $7.95M | Buy |
118,476
+4,240
| +4% | +$277K | 1.65% | 12 |
|
|
2015
Q1 | $6.69M | Buy |
114,236
+12,870
| +13% | +$778K | 1.44% | 14 |
|
|
2014
Q4 | $6.63M | Buy |
101,366
+5,950
| +6% | +$375K | 1.51% | 15 |
|
|
2014
Q3 | $5.51M | Buy |
95,416
+7,755
| +9% | +$431K | 1.34% | 21 |
|
|
2014
Q2 | $4.95M | Buy |
+87,661
| New | +$4.6M | 1.18% | 26 |
|
Other funds holding ABBV
Connors Investor Services's ABBV Position: Q2 2026 in Review
Connors Investor Services increased its AbbVie (ABBV) stake by 0.35% in Q2 2026, buying an estimated $60.5K and bringing the position to 80,288 shares worth $20.2M. The position accounts for 1.75% of the portfolio, ranked #17.
Connors Investor Services first reported a position in ABBV in Q2 2014 and has held it in 49 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Connors Investor Services held 80,288 shares of AbbVie worth $20.2M as of Q2 2026.
- Connors Investor Services bought 281 AbbVie shares in Q2 2026, an estimated $60.5K.
- AbbVie made up 1.75% of Connors Investor Services's portfolio in Q2 2026, its #17 holding.
- Connors Investor Services first reported a position in AbbVie in Q2 2014 and has held it in 49 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.